PEX12, the Pathogenic Gene of Group III Zellweger Syndrome: cDNA Cloning by Functional Complementation on a CHO Cell Mutant, Patient Analysis, and Characterization of Pex12p

REFERENCES

• Berteaux-Lecellier, V., M. Picard, C. Thompson-Coffe, D. Zickler, A. Panvier-Adoutte, and J.-M. Simonet 1995. A nonmammalian homolog of the PAF1 gene (Zellweger syndrome) discovered as a gene involved in caryogamy in the fungus Podospora anserina. Cell 81: 1043–1051.
   PubMed Web of Science ®Google Scholar
• Braverman, N., G. Steel, C. Obie, A. Moser, H. Moser, S. J. Gould, and D. Valle 1997. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat. Genet. 15: 369–376.
   PubMed Web of Science ®Google Scholar
• Chalfie, M., Y. Tu, G. Euskirchen, W. W. Ward, and D. C. Prasher 1994. Green fluorescent protein as a marker for gene expression. Science (Washington, D.C.) 263: 802–805.
   PubMed Web of Science ®Google Scholar
• Chang, C.-C., W.-H. Lee, H. Moser, D. Valle, and S. J. Gould 1997. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Nat. Genet. 15: 385–388.
   PubMedGoogle Scholar
• Chomczynski, P., and N. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-PhOH-chloroform extraction. Anal. Biochem. 162: 156–159.
   PubMed Web of Science ®Google Scholar
• Distel, B., R. Erdmann, S. J. Gould, G. Blobel, D. I. Crane, J. M. Cregg, G. Dodt, Y. Fujiki, J. M. Goodman, W. W. Just, J. A. K. W. Kiel, W.-H. Kunau, P. B. Lazarow, G. P. Mannaerts, H. Moser, T. Osumi, R. A. Rachubinski, A. Roscher, S. Subramani, H. F. Tabak, T. Tsukamoto, D. Valle, I. van der Klei, P. P. van Veldhoven, and M. Veenhuis 1996. A unified nomenclature for peroxisome biogenesis factors. J. Cell Biol. 135: 1–3.
   PubMedGoogle Scholar
• Dodt, G., N. Braverman, C. S. Wong, A. Moser, H. W. Moser, P. Watkins, D. Valle, and S. J. Gould 1995. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat. Genet. 9: 115–125.
   PubMedGoogle Scholar
• Eitzen, G. A., V. I. Titorenko, J. J. Smith, M. Veenhuis, R. K. Szilard, and R. A. Rachubinski 1996. The Yarrowia lipolytica gene PAY5 encodes a peroxisomal integral membrane protein homologous to the mammalian peroxisome assembly factor PAF-1. J. Biol. Chem. 271: 20300–20306.
   PubMedGoogle Scholar
• Fransen, M., C. Brees, E. Baumgart, J. C. Vanhooren, M. Baes, G. P. Mannaerts, and P. P. V. Veldhoven 1995. Identification and characterization of the putative human peroxisomal C-terminal targeting signal import receptor. J. Biol. Chem. 270: 7731–7736.
   PubMedGoogle Scholar
• Fujiki, Y. 1996. Approaches to studies on peroxisome biogenesis and human peroxisome-deficient disorders. Ann. N. Y. Acad. Sci. 804: 491–501.
   PubMedGoogle Scholar
• Fujiki, Y. 1997. Molecular defects in genetic diseases of peroxisomes. Biochim. Biophys. Acta 1361: 235–250.
   PubMedGoogle Scholar
• Fujiki, Y., R. A. Rachubunski, and P. B. Lazarow 1984. Synthesis of a major integral membrane polypeptide of rat liver peroxisomes on free polysomes. Proc. Natl. Acad. Sci. USA 81: 7127–7131.
   PubMed Web of Science ®Google Scholar
• Fukuda, S., N. Shimozawa, Y. Suzuki, S. Tomatsu, T. Tsukamoto, N. Hashiguchi, T. Osumi, M. Masuno, K. Imaizumi, Y. Kuroki, Y. Fujiki, T. Orii, and N. Kondo 1996. Human peroxisome assembly factor-2 (human PAF-2): a gene responsible for group C peroxisome biogenesis disorder in humans. Am. J. Hum. Genet. 59: 1210–1220.
   PubMedGoogle Scholar
• Gould, S. J., J. E. Kalish, J. C. Morrell, J. Bjorkman, A. J. Urquhart, and D. I. Crane 1996. Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTS1 receptor. J. Cell Biol. 135: 85–95.
   PubMed Web of Science ®Google Scholar
• Hess, R., W. Staubli, and W. Reiss 1965. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxyisobutyrate in the rat. Nature 208: 856–858.
   PubMed Web of Science ®Google Scholar
• Hijikata, M., N. Ishii, H. Kagamiyama, T. Osumi, and T. Hashimoto 1987. Structural analysis of cDNA for rat peroxisomal 3-ketoacyl-CoA thiolase. J. Biol. Chem. 262: 8151–8158.
   PubMedGoogle Scholar
• Hoehfeld, J., D. Mertens, F. F. Wiebel, and W.-H. Kunau 1992. Defining components required for peroxisome assembly in Saccharomyces cerevisiae Membrane biogenesis and protein targeting. In: Neupert, W., and R. Lill185–207Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
   Google Scholar
• Kalish, J. E., G. A. Keller, J. C. Morrell, S. J. Mihalik, B. Smith, J. M. Cregg, and S. J. Gould 1996. Characterization of a novel component of the peroxisomal protein import apparatus using fluorescent peroxisomal proteins. EMBO J. 15: 3275–3285.
   PubMedGoogle Scholar
• Kalish, J. E., C. Theda, J. C. Morrell, J. M. Berg, and S. J. Gould 1995. Formation of the peroxisome lumen is abolished by loss of Pichia pastoris Pas7p, a zinc-binding integral membrane protein of the peroxisome. Mol. Cell. Biol. 15: 6406–6419.
   PubMedGoogle Scholar
• Kunau, W.-H., A. Beyer, T. Franken, K. Goette, M. Marzioch, J. Saidowsky, A. Skaletz-Rorowski, and F. F. Wiebel 1993. Two complementary approaches to study peroxisome biogenesis in Saccharomyces cerevisiae: forward and reversed genetics. Biochimie 75: 209–224.
   PubMed Web of Science ®Google Scholar
• Lazarow, P. B., and Y. Fujiki 1985. Biogenesis of peroxisomes. Annu. Rev. Cell Biol. 1: 489–530.
   PubMedGoogle Scholar
• Lazarow, P. B., and H. W. Moser 1995. Disorders of peroxisome biogenesis The metabolic basis of inherited disease7th ed.Scriver, C. R., A. I. Beaudet, W. S. Sly, and D. Valle2287–2324McGraw-Hill, New York, N.Y.
   Google Scholar
• Miura, S., S. Miyazawa, T. Osumi, T. Hashimoto, and Y. Fujiki 1994. Post-translational import of 3-ketoacyl-CoA thiolase into rat liver peroxisomes in vitro. J. Biochem. 115: 1064–1068.
   PubMedGoogle Scholar
• Miyazawa, S., H. Hayashi, M. Hijikata, N. Ishii, S. Furuta, H. Kagamiyama, T. Osumi, and T. Hashimoto 1987. Complete nucleotide sequence of cDNA and predicted amino acid sequence of rat acyl-CoA oxidase. J. Biol. Chem. 262: 8131–8137.
   PubMed Web of Science ®Google Scholar
• Miyazawa, S., T. Osumi, T. Hashimoto, K. Ohno, S. Miura, and Y. Fujiki 1989. Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase resides at the carboxy terminus. Mol. Cell. Biol. 9: 83–91.
   PubMedGoogle Scholar
• Morand, O. H., L.-A. H. Allen, R. A. Zoeller, and C. R. H. Raetz 1990. A rapid selection for animal cell mutants with defective peroxisomes. Biochim. Biophys. Acta 1034: 132–141.
   PubMedGoogle Scholar
• Moser, A. B., M. Rasmussen, S. Naidu, P. A. Watkins, M. McGuiness, A. K. Hajra, G. Chen, G. Raymond, A. Liu, D. Gordon, K. Garnaas, D. S. Walton, O. H. Skjeldal, M. A. Guggenheim, L. G. Jackson, E. R. Elias, and H. W. Moser 1995. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J. Pediatr. 127: 13–22.
   PubMed Web of Science ®Google Scholar
• Motley, A., E. Hettema, B. Distel, and H. Tabak 1994. Differential protein import deficiencies in human peroxisome assembly disorders. J. Cell Biol. 125: 755–767.
   PubMedGoogle Scholar
• Motley, A. M., E. H. Hettema, E. M. Hogenhout, P. Brites, A. L. M. A. ten Asbroek, F. A. Wijburg, F. Baas, H. S. Heijmans, H. F. Tabak, R. J. A. Wanders, and B. Distel 1997. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat. Genet. 15: 377–380.
   PubMedGoogle Scholar
• Niman, H. L., R. A. Houghten, L. E. Walker, R. A. Reisfeld, I. A. Wilson, J. M. Hogle, and R. A. Lerner 1983. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc. Natl. Acad. Sci. USA 80: 4949–4953.
   PubMed Web of Science ®Google Scholar
• Okamoto, H., Y. Suzuki, N. Shimozawa, S. Yajima, M. Masuno, and T. Orii 1992. Transformation and characterization of mutant human fibroblasts defective in peroxisome assembly. Exp. Cell Res. 201: 307–312.
   PubMedGoogle Scholar
• Okumoto, K., A. Bogaki, K. Tateishi, T. Tsukamoto, T. Osumi, N. Shimozawa, Y. Suzuki, T. Orii, and Y. Fujiki 1997. Isolation and characterization of peroxisome-deficient Chinese hamster ovary cell mutants representing human complementation group III. Exp. Cell Res. 233: 11–20.
   PubMedGoogle Scholar
• Okumoto, K., and Y. Fujiki 1997. PEX12 encodes an integral membrane protein of peroxisomes. Nat. Genet. 17: 265–266.
   PubMedGoogle Scholar
• Osumi, T., T. Tsukamoto, S. Hata, S. Yokota, S. Miura, Y. Fujiki, M. Hijikata, S. Miyazawa, and T. Hashimoto 1991. Amino-terminal presequence of the precursor of peroxisomal 3-ketoacyl-CoA thiolase is a cleavable signal peptide for peroxisomal targeting. Biochem. Biophys. Res. Commun. 181: 947–954.
   PubMedGoogle Scholar
• Otera, H., K. Tateishi, K. Okumoto, Y. Ikoma, E. Matsuda, M. Nishimura, T. Tsukamoto, T. Osumi, K. Ohashi, O. Higuchi, and Y. Fujiki 1998. Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: studies with PEX5-defective CHO cell mutants. Mol. Cell. Biol. 18: 388–399.
   PubMed Web of Science ®Google Scholar
• Portsteffen, H., A. Beyer, E. Becker, C. Epplen, A. Pawlak, W.-H. Kunau, and G. Dodt 1997. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nat. Genet. 17: 449–452.
   PubMed Web of Science ®Google Scholar
• Poulos, A., J. Christodoulou, C. W. Chow, J. Goldblatt, B. C. Paton, T. Orii, Y. Suzuki, and N. Shimozawa 1995. Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J. Pediatr. 127: 596–599.
   PubMedGoogle Scholar
• Purdue, P. E., J. W. Zhang, M. Skoneczny, and P. B. Lazarow 1997. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat. Genet. 15: 381–384.
   PubMedGoogle Scholar
• Rachubinski, R. A., Y. Fujiki, R. M. Mortensen, and P. B. Lazarow 1984. Acyl-CoA oxidase and hydratase-dehydrogenase, two enzymes of the peroxisomal β-oxidation system, are synthesized on free polysomes of clofibrate-treated rat liver. J. Cell Biol. 99: 2241–2246.
   PubMedGoogle Scholar
• Reuber, B. E., E. Germain-Lee, C. S. Collins, J. C. Morrell, R. Ameritunga, H. W. Moser, D. Valle, and S. J. Gould 1997. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat. Genet. 17: 445–448.
   PubMed Web of Science ®Google Scholar
• Santos, M. J., S. Hoefler, A. B. Moser, H. W. Moser, and P. B. Lazarow 1992. Peroxisome assembly mutations in humans: structural heterogeneity in Zellweger syndrome. J. Cell. Physiol. 151: 103–112.
   PubMed Web of Science ®Google Scholar
• Saurin, A. J., K. L. B. Borden, M. N. Boddy, and P. S. Freemont 1996. Does this have a familiar RING? Trends Biochem. Sci. 21: 208–214.
   PubMed Web of Science ®Google Scholar
• Shimozawa, N., T. Tsukamoto, Y. Suzuki, T. Orii, and Y. Fujiki 1992. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. J. Clin. Invest. 90: 1864–1870.
   PubMedGoogle Scholar
• Shimozawa, N., T. Tsukamoto, Y. Suzuki, T. Orii, Y. Shirayoshi, T. Mori, and Y. Fujiki 1992. A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science (Washington, D.C.) 255: 1132–1134.
   PubMed Web of Science ®Google Scholar
• Shimozawa, N., et al. Unpublished data.
   Google Scholar
• Slawecki, M. L., G. Dodt, S. Steinberg, A. B. Moser, H. W. Moser, and S. J. Gould 1995. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J. Cell Sci. 108: 1817–1829.
   PubMedGoogle Scholar
• Subramani, S. 1993. Protein import into peroxisomes and biogenesis of the organelle. Annu. Rev. Cell Biol. 9: 445–478.
   PubMedGoogle Scholar
• Swinkels, B. W., S. J. Gould, A. G. Bodnar, R. A. Rachubinski, and S. Subramani 1991. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10: 3255–3262.
   PubMedGoogle Scholar
• Tamura, S., K. Okumoto, R. Toyama, N. Shimozawa, T. Tsukamoto, Y. Suzuki, T. Osumi, N. Kondo, and Y. Fujiki 1998. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I. Proc. Natl. Acad. Sci. USA 95: 4350–4355.
   PubMedGoogle Scholar
• Tan, X., H. R. Waterham, M. Veenhuis, and J. M. Cregg 1995. The Hansenula polymorpha PER8 gene encodes a novel peroxisomal integral membrane protein involved in proliferation. J. Cell Biol. 128: 307–319.
   PubMedGoogle Scholar
• Tateishi, K., K. Okumoto, N. Shimozawa, T. Tsukamoto, T. Osumi, Y. Suzuki, N. Kondo, I. Okano, and Y. Fujiki 1997. Newly identified Chinese hamster ovary cell mutants defective in peroxisome biogenesis represent two novel complementation groups in mammals. Eur. J. Cell Biol. 73: 352–359.
   PubMedGoogle Scholar
• Thieringer, R., and C. R. H. Raetz 1993. Peroxisome-deficient Chinese hamster ovary cells with point mutations in peroxisome assembly factor-1. J. Biol. Chem. 268: 12631–12636.
   PubMedGoogle Scholar
• Tsukamoto, T., A. Bogaki, K. Okumoto, K. Tateishi, Y. Fujiki, N. Shimozawa, Y. Suzuki, N. Kondo, and T. Osumi 1997. Isolation of a new peroxisome deficient CHO cell mutant defective in peroxisome targeting signal-1 receptor. Biochem. Biophys. Res. Commun. 230: 402–406.
   PubMedGoogle Scholar
• Tsukamoto, T., S. Hata, S. Yokota, S. Miura, Y. Fujiki, M. Hijikata, S. Miyazawa, T. Hashimoto, and T. Osumi 1994. Characterization of the signal peptide at the amino terminus of the rat peroxisomal 3-ketoacyl-CoA thiolase precursor. J. Biol. Chem. 269: 6001–6010.
   PubMedGoogle Scholar
• Tsukamoto, T., S. Miura, and Y. Fujiki 1991. Restoration by a 35K membrane protein of peroxisome assembly in a peroxisome-deficient mammalian cell mutant. Nature 350: 77–81.
   PubMedGoogle Scholar
• Tsukamoto, T., S. Miura, T. Nakai, S. Yokota, N. Shimozawa, Y. Suzuki, T. Orii, Y. Fujiki, F. Sakai, A. Bogaki, H. Yasumo, and T. Osumi 1995. Peroxisome assembly factor-2, a putative ATPase cloned by functional complementation on a peroxisome-deficient mammalian cell mutant. Nat. Genet. 11: 395–401.
   PubMedGoogle Scholar
• Tsukamoto, T., N. Shimozawa, and Y. Fujiki 1994. Peroxisome assembly factor 1: nonsense mutation in a peroxisome-deficient Chinese hamster ovary cell mutant and deletion analysis. Mol. Cell. Biol. 14: 5458–5465.
   PubMedGoogle Scholar
• Tsukamoto, T., S. Yokota, and Y. Fujiki 1990. Isolation and characterization of Chinese hamster ovary cell mutants defective in assembly of peroxisomes. J. Cell Biol. 110: 651–660.
   PubMed Web of Science ®Google Scholar
• van den Bosch, H., R. B. H. Schutgens, R. J. A. Wanders, and J. M. Tager 1992. Biochemistry of peroxisomes. Annu. Rev. Biochem. 61: 157–197.
   PubMed Web of Science ®Google Scholar
• Waterham, H. R., Y. de Vries, K. A. Russel, W. Xie, M. Vennhuis, and J. M. Cregg 1996. The Pichia pastoris PER6 gene product is a peroxisomal integral membrane protein essential for peroxisome biogenesis and has sequence similarity to the Zellweger syndrome protein PAF-1. Mol. Cell. Biol. 16: 2527–2536.
   PubMed Web of Science ®Google Scholar
• Wendland, M., and S. Subramani 1993. Presence of cytoplasmic factors functional in peroxisomal protein import implicates organelle-associated defects in several human peroxisomal disorders. J. Clin. Invest. 92: 2462–2468.
   PubMedGoogle Scholar
• Wiemer, E. A., W. M. Nuttley, B. L. Bertolaet, X. Li, U. Francke, M. J. Wheelock, U. K. Anne, K. R. Johnson, and S. Subramani 1995. Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders. J. Cell Biol. 130: 51–65.
   PubMedGoogle Scholar
• Wiemer, E. A. C., S. Brul, W. W. Just, R. van Driel, E. Brouwer-Kelder, M. van den Berg, P. J. Weijers, R. B. H. Schutgens, H. van den Bosch, A. Schram, R. J. A. Wanders, and J. M. Tager 1989. Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts. Eur. J. Cell Biol. 50: 407–417.
   PubMed Web of Science ®Google Scholar
• Yahraus, T., N. Braverman, G. Dodt, J. E. Kalish, J. C. Morrell, H. W. Moser, D. Valle, and S. J. Gould 1996. The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J. 15: 2914–2923.
   PubMed Web of Science ®Google Scholar
• Yajima, S., Y. Suzuki, N. Shimozawa, S. Yamaguchi, T. Orii, Y. Fujiki, T. Osumi, T. Hashimoto, and H. W. Moser 1992. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Hum. Genet. 88: 491–499.
   PubMed Web of Science ®Google Scholar
• Zoeller, R. A., L.-A. H. Allen, M. J. Santos, P. B. Lazarow, T. Hashimoto, A. M. Tartakoff, and C. R. H. Raetz 1989. Chinese hamster ovary cell mutants defective in peroxisome biogenesis. Comparison to Zellweger syndrome. J. Biol. Chem. 264: 21872–21878.
   PubMedGoogle Scholar
• Zoeller, R. A., O. H. Morand, and C. R. H. Raetz 1988. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263: 11590–11596.
   PubMed Web of Science ®Google Scholar